Characterization of cyclin E expression in multiple myeloma and its functional role in seliciclib-induced apoptotic cell death
about
Cyclin-dependent kinase inhibitor therapy for hematologic malignanciesKinase inhibitors as potential agents in the treatment of multiple myeloma.ADP-ribosylation factor 1 (ARF1) takes part in cell proliferation and cell adhesion-mediated drug resistance (CAM-DR).Molecular and cytogenetic changes in multi-drug resistant cancer cells and their influence on new compounds testing.Chromosomal instability and acquired drug resistance in multiple myeloma.The therapeutic potential of cell cycle targeting in multiple myeloma.
P2860
Characterization of cyclin E expression in multiple myeloma and its functional role in seliciclib-induced apoptotic cell death
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Characterization of cyclin E e ...... b-induced apoptotic cell death
@ast
Characterization of cyclin E e ...... b-induced apoptotic cell death
@en
Characterization of cyclin E e ...... b-induced apoptotic cell death
@nl
type
label
Characterization of cyclin E e ...... b-induced apoptotic cell death
@ast
Characterization of cyclin E e ...... b-induced apoptotic cell death
@en
Characterization of cyclin E e ...... b-induced apoptotic cell death
@nl
prefLabel
Characterization of cyclin E e ...... b-induced apoptotic cell death
@ast
Characterization of cyclin E e ...... b-induced apoptotic cell death
@en
Characterization of cyclin E e ...... b-induced apoptotic cell death
@nl
P2093
P2860
P1433
P1476
Characterization of cyclin E e ...... b-induced apoptotic cell death
@en
P2093
Amnon Peled
Arnon Nagler
Avichai Shimoni
Katia Beider
Liat Josefsberg Ben-Yehoshua
Michal Samookh
Olga Ostrovsky
P2860
P304
P356
10.1371/JOURNAL.PONE.0033856
P407
P577
2012-01-01T00:00:00Z